TAYS Sydaenkeskus Oy

At TAYS Sydaenkeskus Oy in Tampere, clinical research in cardiovascular diseases focuses on atrial fibrillation and the prevention of stroke and systemic embolism. These trials are designed to compare treatment options and better understand how to balance protection from clot-related events with safety.

• Prevention of stroke and systemic embolism in atrial fibrillation
• Evaluation of treatment effectiveness and safety in patients at risk for stroke
• Assessment of bleeding risk alongside benefit-risk balance

The research aims to support improved care for people living with irregular heart rhythm by testing whether a new therapy can offer stronger protection and a safer overall profile than current options.

Research in neoplasms at this hospital includes studies in acute lymphoblastic leukemia, with a particular focus on infants. The work is centered on improving outcomes for newly diagnosed patients and advancing treatment approaches for this rare and serious cancer.

• Acute lymphoblastic leukemia in infants
• Improvement of event-free survival and overall treatment outcomes
• Testing a new protocol for a difficult-to-treat pediatric blood cancer

The studies aim to build on earlier results by evaluating whether updated treatment strategies can help children with leukemia achieve better disease control and longer-lasting remission.